Immunotherapy of cancer by IL-12-based cytokine combinations

By Weiss Jonathan M   Subleski Jeff J   Wigginton Jon M   Wiltrout Robert H  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 11, 2007-11 ,pp. : 1705-1721

Informa Healthcare

Access to resources Recommend Favorite

Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside

By Kurtz Jean-Emmanuel   Dufour Patrick  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 6, 2010-06 ,pp. : 951-958

Informa Healthcare

Access to resources Recommend Favorite

15-Deoxy-Δ^12,14-prostaglandin J₂ Inhibits IL-10 and IL-12 Production by Macrophages

By Azuma Y.   Shinohara M.   Wang P-L.   Ohura K.  

Biochemical and Biophysical Research Communications, Vol. 283, Iss. 2, 2001-05 ,pp. : 344-346

Elsevier

Access to resources Recommend Favorite

Adoptive T-cell therapy for the treatment of solid tumours

By Knutson Keith L   Almand Bond   Mankoff David A   Schiffman Kathy   Disis Mary L  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 1, 2002-01 ,pp. : 55-66

Informa Healthcare

Access to resources Recommend Favorite

Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine

By Xu Ai-Jing   Zhu Wei   Tian Fei   Yan Li-Hua   Li Tang  

Molecular and Cellular Biochemistry, Vol. 344, Iss. 1-2, 2010-11 ,pp. : 163-171

Springer Publishing Company

Access to resources Recommend Favorite